Elevance Health, Inc.
ELV
$342.93
-$5.25-1.51%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 41.18B | 42.42B | 41.76B | 41.48B | 36.77B |
| Total Other Revenue | 8.57B | 8.30B | 8.02B | 7.41B | 8.67B |
| Total Revenue | 49.75B | 50.71B | 49.78B | 48.89B | 45.44B |
| Cost of Revenue | 38.07B | 38.14B | 36.71B | 35.31B | 33.50B |
| Gross Profit | 11.68B | 12.57B | 13.07B | 13.58B | 11.94B |
| SG&A Expenses | 10.75B | 10.65B | 10.29B | 10.28B | 10.51B |
| Depreciation & Amortization | 164.00M | 162.00M | 147.00M | 155.00M | 180.00M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 48.98B | 48.95B | 47.14B | 45.75B | 44.19B |
| Operating Income | 766.00M | 1.76B | 2.63B | 3.14B | 1.26B |
| Income Before Tax | 215.00M | 1.41B | 2.29B | 2.80B | 606.00M |
| Income Tax Expenses | -331.00M | 219.00M | 548.00M | 613.00M | 193.00M |
| Earnings from Continuing Operations | 546.00M | 1.19B | 1.74B | 2.18B | 413.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1.00M | 2.00M | -1.00M | -1.00M | 5.00M |
| Net Income | 547.00M | 1.19B | 1.74B | 2.18B | 418.00M |
| EBIT | 766.00M | 1.76B | 2.63B | 3.14B | 1.26B |
| EBITDA | 1.17B | 2.14B | 3.01B | 3.51B | 1.65B |
| EPS Basic | 2.47 | 5.32 | 7.74 | 9.64 | 1.81 |
| Normalized Basic EPS | 1.13 | 3.94 | 6.36 | 7.72 | 2.50 |
| EPS Diluted | 2.47 | 5.32 | 7.72 | 9.61 | 1.81 |
| Normalized Diluted EPS | 1.13 | 3.94 | 6.34 | 7.69 | 2.50 |
| Average Basic Shares Outstanding | 221.80M | 223.30M | 225.20M | 226.40M | 231.10M |
| Average Diluted Shares Outstanding | 221.80M | 223.70M | 225.80M | 227.20M | 231.10M |
| Dividend Per Share | 1.71 | 1.71 | 1.71 | 1.71 | 1.63 |
| Payout Ratio | 68.92% | 32.04% | 22.09% | 17.68% | 89.23% |